Treatment of progressive central precocious puberty with leuprorelin depot;Leuprorelindepot zur behandlung der progressiven pubertas praecox vera

Monatsschrift fur Kinderheilkunde

Volumn 147, Issue 7, 1999, Pages 638-647

  Partsch, C J ^a   Peter, M ^b   Sippel, W G ^b   Akkurt, I ^b   Bachran, R ^b   Beyer, P ^b   Brack, C ^b   Bramswig J H ^b   Brand, M ^b   Dorr H G ^b   Erxleben, B ^b   Grulich Henn, J ^b   Hauffa, B P ^b   Hecker, R ^b   Heidemann, P ^b   Heinrich, U ^b   Irle, U ^b   Kim Berger, H S ^b   Korsch, E ^b   Mix, M ^b   Mohnike, K ^b   Muhlenberg R ^b   Schnabel, D ^b   Schonau E ^b   Sorgo, W ^b   Tittel, B ^b   Vogel, C ^b   Wiebel, J ^b   Wygold, T ^b   Zeller, R ^b   more..

^a UNIVERSITY OF KIEL   (Germany)

^b NONE

Author keywords

Bone maturation; GnRH agonist; Gonadotropins; Growth; Precocious puberty

Indexed keywords

BUSERELIN; FOLLITROPIN; GONADORELIN AGONIST; GOSERELIN; LEUPRORELIN; LUTEINIZING HORMONE; TRIPTORELIN;

ARTICLE; BONE AGE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG FORMULATION; FEMALE; GOOD CLINICAL PRACTICE; HORMONAL THERAPY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPHYSIS FUNCTION; MULTICENTER STUDY; PRECOCIOUS PUBERTY; SUBCUTANEOUS DRUG ADMINISTRATION; VAGINA BLEEDING;

EID: 0032791047     PISSN: 00269298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001120050474     Document Type: Article

References (44)

1. Bayley N, Pinneau S (1952) Tables for predicting adult height from skeletal age. J Pediatr 40:423-441
2. Brandt I, Reinken L (1980) Die Wachstumsgeschwindigkeit gesunder Kinder in den ersten 16 Lebensjahren: Longitudinale Entwicklungsstudie Bonn-Dortmund. Klin Padiatr 200:451-456
3. Brauner R, Thibaud E, Rappaport R (1987) Pubertés précoces centrales spontanément régressives chez la fille. Ann Pediatr 34:70-74
4. Bridges NA, Christopher JA, Hindmarsh PC, Brook CGD (1994) Sexual precocity: sex incidence and etiology. Arch Dis Child 70:116-118
5. Carel J-C, Lahlou N, Guazarotti L, Joubert-Collin M, Roger M, Colle M, and The French Leuprorelin Trial Group, and Chaussain JL (1995) Treatment of central precocious puberty with depot leuprorelin. Eur J Endocrinol 132:699-704
6. Clemons R, Kappy MS, Stuart TE, Perelman AH, Hoekstra FT (1993) Long-term effectiveness of depot gonadotropin-releasing hormone analogue in the treatment of children with central precocious puberty. Am J Dis Child 147:653-657
7. Comite F, Cutler Jr GB, Rivier J, Vale WW, Loriaux DL, Crowley Jr WF (1981 ) Short-term treatment of idiopathic precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. N Engl J Med 305:1546-1550
8. Cook JS, Doty KL, Conn PM, Hansen JR (1992) Assessment of depot leuprolide acetate dose-adequacy for central precocious puberty. J Clin Endocrinol Metab 74:1206-1209
9. Crowley Jr WF, Comité F, Vale WW, Rivier J, Loriaux DL, Cutler Jr GB (1981) Therapeutic use of pituitary desensitization with a long-acting LHRH agonist: a potential new treatment for idiopathic precocious puberty. J Clin Endocrinol Metab 52:370-372
10. Fontoura M, Brauner B, Prevot C, Rappaport R (1989) Precocious puberty in girls: early diagnosis of a slowly progressing variant. Arch Dis Child 64:1170-1176
11. Greulich WW, Pyle SI (1959) Radiographic atlas of skeletal development of the hand and wrist. Stanford University Press, Stanford
12. Kappy M, Stuart T, Perelman A (1988) Efficacy of leuprolide therapy in children with central precocious puberty. Am J Dis Child 142:1061-1064
13. Kappy M, Stuart T, Perelman A, Clemons R (1989) Suppression of gonadotropin secretion by a long-acting gonadotropin-releasing hormone analog (leuprolide acetate, Lupron Depot) in children with precocious puberty. J Clin Endocrinol Metab 69:1087-1089
14. Kobayashi Y, Murata A, Yasuda T, Minagawa M, Wataki K, Ohnishi H, Niimi H (1994) Suppression of sex steroids by a gonadotropin-releasing hormone agonist increases serum growth hormone-binding protein activity in girls with central precocious puberty. Clin Endocrinol (Oxf) 40:351-355
15. Kolmer M, Schulz U, Herkner K, Frisch H, Waldhauser F (1991) Undulierender Verlauf einer Pubertas praecox. Padiatr Padol 26:271-274
16. Kreiter ML, Cara JF, Rosenfield RL (1993) Modifying the outcome of complete precocious puberty. To treat or not to treat. In: Grave GD, Cutler Jr GB (eds) Sexual precocity: etiology, diagnosis, and management. Raven Press, New York, pp 109-120
17. Lee PA (1981) Medroxyprogesterone therapy for sexual precocity in girls. Am J Dis Child 135:443-445
18. Lee PA (1993) Treatment of central precocious puberty with Depot Lupron. In: Grave GD, Cutler Jr GB (eds) Sexual precocity: etiology, diagnosis, and management. Raven Press, New York, pp 139-150
19. Lee PA, Page JG, and the Leuprolide Study Group (1989) Effects of leuprolide in the treatment of central precocious puberty. J Pediatr 114:321-324
20. Neely EK (1995) A multicenter trial of depot leuprolide for central precocious puberty. In: Plant TM, Lee PA (eds) the neurobiology of puberty. Journal of Endocrinology Ltd, Bristol, pp 313-318
21. Neely EK, Hintz RL, Parker B, Bachrach LK, Cohen P, Olney R, Wilson DM (1992) Two-year results of treatment with depot leuprolide acetate for central precocious puberty. J Pediatr 121:634-640
22. Oostdijk W, Hümmelink R, Odink RJH, Partsch C-J, Drop SLS, Lorenzen F, Sippell WG, Velde EA van der, Schultheiss H on behalf of the Dutch-German Precocious Puberty Study Group (1990) Treatment of children with central precocious puberty by a slow-release GnRH agonist. Eur J Pediatr 149:308-313
23. Parker KL, Lee PA (1989) Depot leuprolide actetate for treatment of precocious puberty. J Clin Endocrinol Metab 69:689-691
24. Parker KL, Baens-Bailon RG, Lee PA (1991) Depot leuprolide acetate dosage for sexual precocity. J Clin Endocrinol Metab 73:50-52
25. Partsch C-J, Hümmelink R, Sippell WG, Oostdijk W, Odink RJH, Drop SLS (1987) Use of decapeptyl-depot in girls with central precocious puberty. In: Massi GB, Bruni V (eds) Pediatric and adolescent gynecology. CIC Edizioni Internationali, Rom, pp 417-422
26. Partsch C-J, Hümmelink R, Lorenzen F, Sippell WG und die Deutsche Decapeptyl-Depot Studiengruppe (1989) Bedeutung und Charakteristika des LHRH-Testes in der Diagnostik der vorzeitigen Pubertätsentwickluung bei Mädchen: Der stimulierte LH/FSH-Quotient differenziert zwischen zentraler Pubertas praecox und prämaturerThelarche. Monatsschr Kinderheilkd 137:284-288
27. Partsch C-J, Hümmelink R, Sippell WG (1990) Reference ranges of lutropin and follitropin in the luliberin test in prepubertal and pubertal children using a monoclonal immunoradiometric assay. J Clin Chem Clin Biochem 28:49-52
28. Partsch C-J, Peter M, Heger S, Sippell WG (1998) Transitorische Pubertas praecox vera. Monatsschr Kinderheilkd 146:678-682
29. Pasquino AM, Cives C, Maciocci M, Tebaldi L, Musleh M, Boscherini B (1989) Transient true precocious puberty. A report of five cases. Eur J Pediatr 148:735-736
30. Pelzer V, Ditfurth M von, Wendel U (1990) Differentialdiagnostische Abgrenzung der Pubertas praecox gegen die prämature Thelarche mit Hilfe der Ultrasonographie und dem stimulierten LH/FSH-Quotienten. Geburtshilfe Frauenheilkd 50:964-968
31. Pescovitz OH, Hench KD, Barnes KM, Loriaux DL, Cutler Jr GB (1988) Premature thelarche and central precocious puberty: the relationship between clinical presentation and the gonadotropin response to luteinizing hormone-releasing hormone. J Clin Endocrinol Metab 67:474-479
32. Reinken L, Oost G van (1992) Longitudinale Körperentwicklung gesunder Kinder von 0 bis 18 Jahren. Klin Padiatr 204:129-133
33. Reinken L, Stolley H, Droese W, Oost G van (1980) Longitudinale Körperentwicklung gesunder Kinder. II. Größe, Gewicht, Hautfettfalten von Kindern im Alter von 1,5 bis 16 Jahren. Klin Padiatr 192:25-33
34. Roger M, Chaussain J-L, Berlier P, Bost M, Canlorbe P, Colle, M, Francois R, Garandeau P, Lahlou N, Morel Y (1986) Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp-6-LHRH microcapsules. J Clin Endocrinol Metab 62:670-677
35. Rosenfield RL (1994) Selection of children with precocious puberty for treatment with gonadotropin releasing hormone analogs. J Pediatr 124:989-991
36. Schwarz HP, Tschaeppeler H, Zuppinger K (1990) Case report: unsustained central sexual precocity in four girls. Am J Med Sci 299:260-264
37. Schroor EJ, Weissenbruch MM van, Delemarre-van de Waal HA (1995) Pathophysiology of central precocious puberty. In: Plant TM, Lee PA (eds) The neurobiology of puberty. Journal of Endocrinology Ltd, Bristol, pp 199-208
38. Sonis WA, Comite F, Blue J, Pescovitz OH, Rahn CW, Hench KD, Cutler GB Jr, Loriaux DL, Klein RP (1985) Behavior problems and social competence in girls with true precocious puberty. J Pediatr 106:156-160
39. Sorgo W, Kiraly E, Homoki J, Heinze E, Teller WM, Bierich JR, Moeller H, Ranke MB, Butenandt O, Knorr D (1987) The effects of cyproterone acetate on statural growth in children with precocious puberty. Acta Endocrinol 115:44-56
40. Tanaka T, Hibi I, Kato K, Saito S, Shimizu N, Suwa S, Nakajima H (1991) A dose finding study of a super long-acting luteinizing hormone-releasing hormone analog (leuprorelin acetate depot, TAP-144-SR) in the treatment of central precocious puberty. Endocr J 38:369-376
41. Tanner JM (1962) Growth at adolescence. 2nd edn. Blackwell, Oxford
42. Thamdrup E (1961) Precocious sexual development. A clinical study of 100 children. Munksgaard, Kopenhagen
43. Werder EA, Mürset G, Zachmann M, Brook CGD, Prader A (1974) Treatment of precocious puberty with cyproterone acetate. Pediatr Res 8:248-256
44. Witchel SF, Baens-Bailon RG, Lee PA (1996) Treatment of central precocious puberty: comparison of urinary gonadotropin excretion and gonadotropin-releasing hormone (GnRH) stimulation tests in monitoring GnRH analog therapy. J Clin Endocrinol Metab 81:1353-1356